Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05791669
Other study ID # PGIDS/BHRC/21/13
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date August 1, 2021
Est. completion date November 8, 2022

Study information

Verified date November 2022
Source Postgraduate Institute of Dental Sciences Rohtak
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was conducted to assess the efficacy of 38% Silver Diamine fluoride and compare it with 5% sodium fluoride varnish in arresting interproximal caries in primary molars at 12 months follow-up. Bitewing radiographs were taken to diagnose as well as to assess caries depth at follow up visits. Each bitewing was scored based on ICCMS radiographic criteria and was compared (follow-ups to baseline)to check for caries arrest. Interproximal caries included in this study, according to ICCMS criteria, were at stages- RA - caries limited to outer half of enamel RA2 - caries limited to the inner half of enamel RA3 - caries limited to outer third of dentine RA4 - caries limited to middle third of dentine


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date November 8, 2022
Est. primary completion date August 2, 2022
Accepts healthy volunteers No
Gender All
Age group 5 Years to 9 Years
Eligibility Inclusion Criteria: 1. Children aged 5 to 9 years. 2. Presence of at least 2 primary molars with interproximal caries. 3. Carious lesions of enamel or outer or middle third of dentin in primary molars, as assessed by bitewing radiographs with ICCMSTM scoring (RA1, RA2, RA3, RB4). Exclusion Criteria: 1. Presence of advanced carious lesions reaching inner third of dentin detected by bitewing radiographic examinations ICCMSTM (RC5, RC6). 3. Children or adolescents that refuse to participate in the study or present negative behaviours. 4. Teeth with premature hypermobility 5. Both physically and mentally disabled children

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Silver diamine fluoride
Silver diamine fluoride is a topical medication composed of 25% silver, 5% fluoride, 8% ammonia, and 62% Deionized water, used to treat and prevent dental caries and relieve dentinal hypersensitivity.
Sodium fluoride varnish
It is a topical application with an active ingredient of 5% sodium fluoride(22,600ppm fluoride).it prolongs the contact time between the fluoride and tooth surface and promotes remineralization and inhibits demineralization.

Locations

Country Name City State
India Post graduate institute of dental sciences Rohtak Haryana

Sponsors (1)

Lead Sponsor Collaborator
Postgraduate Institute of Dental Sciences Rohtak

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Caries arrest Assessment with bitewing radiographs based on ICCMS radiographic scoring system 12 months
See also
  Status Clinical Trial Phase
Completed NCT04509232 - Assessing Parental Acceptance to Silver Diamine Fluoride Staining Before and After Masking the Colour With Glass Ionomer N/A
Recruiting NCT04642846 - Clinical and Laboratory Assessments of Effectiveness of Silver Diamine Fluoride (SDF) in Arresting Caries Among Children and Parental Satisfaction N/A
Recruiting NCT05733676 - Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment N/A
Recruiting NCT04255251 - Effectiveness Silver Diamine Fluoride Versus Sodium Fluoride in Arresting Caries Around Crown Margins in Older Adults Early Phase 1
Not yet recruiting NCT04373356 - Non-invasive Caries Management: Clinical Study N/A